GLP-1 Lifestyle Program for Obesity

(PRESERVE GLP-1 Trial)

Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Florida
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This study will test whether adding a lifestyle program to GLP-1 medication treatment can help preserve muscle, reduce cardiovascular risk, and improve quality of life in adults with overweight or obesity. About 670 adults who are starting a GLP-1 medication for weight loss will be enrolled. Participants will be randomly assigned to either a 6-month YMCA lifestyle program that includes resistance exercise and nutrition support, or to enhanced usual care with monthly health education workshops. Study assessments will occur at baseline, 6 months, and 12 months. The main outcome is the change in appendicular lean tissue mass measured by DXA at 6 months. Other outcomes include cardiovascular risk, quality of life, bone density, total lean mass, weight loss, dietary intake, and physical activity.

Are You a Good Fit for This Trial?

This trial is for adults with overweight or obesity who are starting a GLP-1 medication for weight loss. Participants should be able to join exercise and nutrition programs and attend regular study visits.

Inclusion Criteria

I am between 30 and 79 years old.
Obesity (BMI ≥30 kg/m²), or overweight (BMI ≥27 kg/m²) with at least one weight-related comorbidity such as hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease
I have been prescribed a GLP-1 medication for weight loss.
See 3 more

Exclusion Criteria

I am planning to have weight-loss surgery or a weight-loss device implanted soon.
Known or suspected alcohol or recreational drug abuse
Failure to provide informed consent
See 11 more

What Are the Treatments Tested in This Trial?

Interventions

  • Enhanced Usual Care Health Education
  • GLP-1 Lifestyle Management Program

Trial Overview

The study compares two approaches: one group gets a YMCA lifestyle program with resistance exercise and nutrition support, while the other receives monthly health education workshops. Both groups use GLP-1 medications. The main goal is to see which approach better preserves muscle over 6 months.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: GLP-1 Lifestyle Management ProgramExperimental Treatment1 Intervention
Group II: Enhanced Usual CareActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Florida

Lead Sponsor

Trials
1,428
Recruited
987,000+

National Institute on Minority Health and Health Disparities (NIMHD)

Collaborator

Trials
473
Recruited
1,374,000+